Dosage form: liquid
Ingredients: MAGNESIUM HYDROXIDE 1200mg in 30mL, ALUMINUM HYDROXIDE 1200mg in 30mL
Labeler: Cardinal Health
NDC Code: 55154-9431

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Mag-Al Liquid

Active ingredient

Delivers 30 mL

Each 5 mL (teaspoonful) contains 200 mg Aluminum Hydroxide (equiv to dried gel, USP) and 200 mg Magnesium Hydroxide and provides approximately 9 mEq of acid-neutralizing capacity (ANC)

Each 30 mL Contains:

Magnesium Hydroxide 1200 mg

Aluminum Hydroxide 1200 mg



A Sugar Free Antacid

Keep Out of Reach of Children

This package is intended for institutional use only. Keep this and all drugs out of the reach of children.


Indications: As an antacid for symptomatic relief of hyperacidity associated with the diagnosis of peptic ulcer, gastritis, peptic esophagitis, gastric hyperacidity, or hiatal hernia.


The maximum recommended daily dosage of this product is 80 mL (16 teaspoonfuls). Do not take more than this dosage in a 24-hour period or use this dosage for more than 2 weeks except under the advice and supervision of a physician. Do not use this product except under the advice and supervision of a physician if you have kidney disease. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

Prolonged use of aluminum-containing antacids in patients with renal failure may result in or worsen dialysis osteomalacia. Elevated tissue aluminum levels contribute to the development of the dialysis encephalopathy and osteomalacia syndromes. Small amounts of aluminum are absorbed from the gastrointestinal tract and renal excretion of aluminum is impaired in renal failure. Aluminum is not well removed by dialysis because it is bound to albumin and transferrin, which do not cross dialysis membranes. As a result, aluminum is deposited in bone, and dialysis osteomalacia may develop when large amounts of aluminum are ingested orally by patients with impaired renal function.

Aluminum forms insoluble complexes with phosphate in the gastrointestinal tract, thus decreasing phosphate absorption. Prolonged use of aluminum-containing antacids by normophosphatemic patients may result in hypophosphatemia if phosphate intake is not adequate. In its more severe forms, hypophosphaternia can lead to anorexia, malaise, muscle weakness, and osteomalacia.

DRUG INTERACTION PRECAUTION: Ask a doctor or pharmacist before use if you are presently taking a prescription drug. Antacids may interact with certain prescription drugs.


Shake well before using. Adults and children 12 years and older: 10 mL to 20 mL (2 to 4 teaspoonfuls) four times a day or as directed by a physician. Children under 12 years: consult a physician.

Inactive ingredients

Antifoam, butylparaben, hydroxypropyl methylcellulose, flavoring, propylene glycol, propylparaben, purified water, sodium saccharin, and sorbitol solution.

Sodium content: 4 mg/5 ml


Keep tightly closed. Store at Controlled Room Temperature, 20-25 C (68-77 F). [See USP]. Protect from freezing.


How Supplied: White colored, peppermint flavored liquid supplied in the following oral dosage form: NDC 0121-1760-30 (unit dose cups of 30 mL, 10 x 10s).

*Maalox is a registered trademark of Novartis Consumer Health, Inc.

Pharmaceutical Associates, Inc.

Subsidiary of Beach Products, Inc.

201 Delaware Street

Greenville, SC 29605

(800) 845-8210


Principal Display Panel

Mag-Al Liquid

5 Unit Dose Cups

magnesium hydroxide, aluminum hydroxide liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55154-9431(NDC:0121-1760)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Inactive Ingredients
Ingredient NameStrength
Product Characteristics
FlavorPEPPERMINTImprint Code
#Item CodePackage Description
1NDC:55154-9431-55 CUP, UNIT-DOSE (CUP) in 1 BAG
130 mL in 1 CUP, UNIT-DOSE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other06/07/2011
Labeler - Cardinal Health (188557102)
Cardinal Health188557102REPACK

Revised: 06/2011
Cardinal Health

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.